Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03918109 · ClinicalTrials.gov registry record · Phase 1
OTO-313 in Subjects With Subjective Tinnitus
A Phase 1 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT03918109 is a Phase 1 study that has completed, run by Otonomy. The registered enrollment target is 43 participants.
The verdict
NCT03918109, a Phase 1 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, tolerability, plasma pharmacokinetics (PK), and exploratory efficacy of OTO-313 administered as an intratympanic injection for the treatment of subjective tinnitus.
Interventions
- DRUG Placebo
- DRUG OTO-313
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2020-05-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03918109
The ClinicalTrials.gov registry entry for NCT03918109 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03918109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03918109 about?
NCT03918109 is a clinical study titled "OTO-313 in Subjects With Subjective Tinnitus". The purpose of this study is to evaluate the safety, tolerability, plasma pharmacokinetics (PK), and exploratory efficacy of OTO-313 administered as an intratympanic injection for the treatment of subjective tinnitus.
What is the current status of trial NCT03918109?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2019-04-04. Estimated completion is 2020-05-29.
What interventions are being tested in trial NCT03918109?
The interventions under investigation include: Placebo (DRUG), OTO-313 (DRUG).
Who is sponsoring clinical trial NCT03918109?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.